Cerebrospinal fluid, also called CSF, is made by tissue called the choroid plexus in the ventricles (hollow spaces) in the brain. It flows in and around the brain and spinal cord to help cushion them from injury and provide nutrients. The loss of CSF causes the previously cushioned brain to sag inside the skull, which results in a headache. Loss of fluid also causes a lowering of pressure within the skull, a condition called intracranial hypotension. According to market research study published by publisher, the global cerebrospinal fluid management market stood at around USD 1,442 million in 2021 and is projected to rise to a worth of USD 2,140 million by 2028 end, thereby garnering a CAGR of 5.8% during 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cerebrospinal fluid management market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cerebrospinal fluid management industry. This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for cerebrospinal fluid management can be segmented by product: CSF shunts, CSF drainage systems. Cerebrospinal fluid management market is further segmented by end user: hospitals & clinics, ambulatory surgical centers (ASCs), neurological centers. Based on region, the cerebrospinal fluid management market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). By product: - CSF shunts - CSF drainage systems By end user: - hospitals & clinics - ambulatory surgical centers (ASCs) - neurological centers By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The report has also analysed the competitive landscape of the global cerebrospinal fluid management market with some of the key players being Argi Grup, B. Braun Melsungen AG, Beckersmith Medical, Inc, Biometrix BV, Integra LifeSciences Corporation, Medtronic plc, Moller Medical GmbH,, Natus Medical Incorporated, SOPHYSA SA, Spiegelberg GmbH & Co. KG, Stryker Corporation, Wellong Instruments Co., Ltd., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global cerebrospinal fluid management market. - To classify and forecast the global cerebrospinal fluid management market based on product, end user, region. - To identify drivers and challenges for the global cerebrospinal fluid management market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cerebrospinal fluid management market. - To identify and analyze the profile of leading players operating in the global cerebrospinal fluid management market. Why Choose This Report - Gain a reliable outlook of the global cerebrospinal fluid management market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.